Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,003 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BRM270 Inhibits the Proliferation of CD44 Positive Pancreatic Ductal Adenocarcinoma Cells via Downregulation of Sonic Hedgehog Signaling.
Huynh DL, Koh H, Chandimali N, Zhang JJ, Kim N, Kang TY, Ghosh M, Gera M, Park YH, Kwon T, Jeong DK. Huynh DL, et al. Among authors: park yh. Evid Based Complement Alternat Med. 2019 Feb 24;2019:8620469. doi: 10.1155/2019/8620469. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31049070 Free PMC article.
Novel phyto-derivative BRM270 inhibits hepatocellular carcinoma cells proliferation by inducing G2/M phase cell cycle arrest and apoptosis in xenograft mice model.
Kumar Mongre R, Sharma N, Singh Sodhi S, Ghosh M, Kumar Singh A, Kim N, Park YH, Shin YG, Kim SJ, Jiao Jiao Z, Huynh DL, Jeong DK. Kumar Mongre R, et al. Among authors: park yh. Biomed Pharmacother. 2017 Mar;87:741-754. doi: 10.1016/j.biopha.2017.01.006. Epub 2017 Jan 19. Biomed Pharmacother. 2017. PMID: 28110264
Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma.
Mongre RK, Sodhi SS, Sharma N, Ghosh M, Kim JH, Kim N, Park YH, Shin YG, Kim SJ, Jiao ZJ, Huynh do L, Jeong DK. Mongre RK, et al. Among authors: park yh. Int J Oncol. 2016 Jan;48(1):84-98. doi: 10.3892/ijo.2015.3245. Epub 2015 Nov 13. Int J Oncol. 2016. PMID: 26573874 Free PMC article.
Analysis of retinal and choroidal microvascular changes using optical coherence tomography and optical coherence tomography angiography in patients with acute leukemia.
Lee JH, Kim JJ, Hong SY, Kim GH, Kim JY, Kim RY, Kim M, Park YG, Kim YJ, Cho BS, Lee S, Kim HJ, Park YH. Lee JH, et al. Among authors: park yh. Graefes Arch Clin Exp Ophthalmol. 2024 May 7. doi: 10.1007/s00417-024-06504-y. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 38713398
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial.
Fehm T, Cottone F, Dunton K, André F, Krop I, Park YH, De Laurentiis M, Miyoshi Y, Armstrong A, Borrego MR, Yerushalmi R, Duhoux FP, Takano T, Lu W, Egorov A, Kim SB. Fehm T, et al. Among authors: park yh. Lancet Oncol. 2024 May;25(5):614-625. doi: 10.1016/S1470-2045(24)00128-1. Lancet Oncol. 2024. PMID: 38697155 Free article. Clinical Trial.
Functionalized MXene ink enables environmentally stable printed electronics.
Ko TY, Ye H, Murali G, Lee SY, Park YH, Lee J, Lee J, Yun DJ, Gogotsi Y, Kim SJ, Kim SH, Jeong YJ, Park SJ, In I. Ko TY, et al. Among authors: park yh, park sj. Nat Commun. 2024 Apr 24;15(1):3459. doi: 10.1038/s41467-024-47700-y. Nat Commun. 2024. PMID: 38658566 Free PMC article.
Constipation anti-aging effects by dairy-based lactic acid bacteria.
Jaafar MH, Xu P, Mageswaran UM, Balasubramaniam SD, Solayappan M, Woon JJ, Teh CS, Todorov SD, Park YH, Liu G, Liong MT. Jaafar MH, et al. Among authors: park yh. J Anim Sci Technol. 2024 Jan;66(1):178-203. doi: 10.5187/jast.2023.e93. Epub 2024 Jan 31. J Anim Sci Technol. 2024. PMID: 38618031 Free PMC article.
Intravascular imaging-guided percutaneous coronary intervention in patients with acute myocardial infarction and cardiogenic shock.
Joh HS, Lee SH, Jo J, Kim HK, Lim WH, Kim HL, Seo JB, Chung WY, Kim SH, Zo JH, Kim MA, Kim MC, Kim JH, Hong YJ, Ahn YK, Jeong MH, Hur SH, Kim DI, Chang K, Park HS, Bae JW, Jeong JO, Park YH, Yun KH, Yoon CH, Kim Y, Hwang JY, Kim HS, Hong D, Kwon W, Choi KH, Park TK, Yang JH, Song YB, Hahn JY, Choi SH, Gwon HC, Lee JM; KAMIR Investigators. Joh HS, et al. Among authors: park yh, park hs, park tk. Rev Esp Cardiol (Engl Ed). 2024 Apr 10:S1885-5857(24)00125-7. doi: 10.1016/j.rec.2024.03.009. Online ahead of print. Rev Esp Cardiol (Engl Ed). 2024. PMID: 38609042 English, Spanish.
Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Non-ST-Elevation Myocardial Infarction.
Kim CH, Lee SH, Kim HK, Kim MC, Kim JH, Hong YJ, Ahn YK, Jeong MH, Hur SH, Kim DI, Chang K, Park HS, Bae JW, Jeong JO, Park YH, Yun KH, Yoon CH, Kim Y, Hwang JY, Kim HS, Choi KH, Park TK, Yang JH, Song YB, Hahn JY, Choi SH, Gwon HC, Lee JM; KAMIR-NIH Investigators. Kim CH, et al. Among authors: park yh, park hs, park tk. Circ J. 2024 Apr 11. doi: 10.1253/circj.CJ-24-0129. Online ahead of print. Circ J. 2024. PMID: 38599833 Free article.
Intravascular Imaging-Guided Optimization of Complex Percutaneous Coronary Intervention by Sex: A Subgroup Analysis of the RENOVATE-COMPLEX-PCI Trial.
Cha JH, Lee JM, Choi KH, Lee JY, Lee SJ, Lee SY, Kim SM, Yun KH, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Park YH, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Kang MG, Koh JS, Lee KY, Lim YH, Cho YH, Cho JM, Jang WJ, Chun KJ, Hong D, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY, Lee WS, Song YB; RENOVATE-COMPLEX-PCI Investigators. Cha JH, et al. Among authors: park yh, park tk. JAMA Cardiol. 2024 May 1;9(5):466-474. doi: 10.1001/jamacardio.2024.0291. JAMA Cardiol. 2024. PMID: 38568686 Clinical Trial.
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
Martín M, Lim E, Chavez-MacGregor M, Bardia A, Wu J, Zhang Q, Nowecki Z, Cruz FM, Safin R, Kim SB, Schem C, Montero AJ, Khan S, Bandyopadhyay R, Moore HM, Shivhare M, Patre M, Martinalbo J, Roncoroni L, Pérez-Moreno PD, Sohn J; acelERA Breast Cancer Study Investigators. Martín M, et al. J Clin Oncol. 2024 Mar 27:JCO2301500. doi: 10.1200/JCO.23.01500. Online ahead of print. J Clin Oncol. 2024. PMID: 38537155
Engineering small-molecule analogues of altiratinib via CREB-regulated transcription co-activator 3-target screening for the development of potent and safe topical therapeutics against skin hyperpigmentary diseases.
Lee JH, An H, Kwon H, Lee SJ, Park YH, Hwang JS, Kim MY, Hwang H, Kim JY, Lee SJ, Chang SE, Song Y. Lee JH, et al. Among authors: park yh. Clin Transl Med. 2024 Mar;14(3):e1625. doi: 10.1002/ctm2.1625. Clin Transl Med. 2024. PMID: 38481372 Free PMC article. No abstract available.
Cost-Effectiveness of Intravascular Imaging-Guided Complex PCI: Prespecified Analysis of RENOVATE-COMPLEX-PCI Trial.
Hong D, Lee J, Lee H, Cho J, Guallar E, Choi KH, Lee SH, Shin D, Lee JY, Lee SJ, Lee SY, Kim SM, Yun KH, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Park YH, Lee WS, Park TK, Yang JH, Choi SH, Gwon HC, Song YB, Hahn JY, Kang D, Lee JM; RENOVATE-COMPLEX-PCI Investigators. Hong D, et al. Among authors: park yh, park tk. Circ Cardiovasc Qual Outcomes. 2024 Mar;17(3):e010230. doi: 10.1161/CIRCOUTCOMES.123.010230. Epub 2024 Mar 13. Circ Cardiovasc Qual Outcomes. 2024. PMID: 38477162 Clinical Trial.
The North Equatorial Current and rapid intensification of super typhoons.
Kang SK, Kim SH, Lin II, Park YH, Choi Y, Ginis I, Cione J, Shin JY, Kim EJ, Kim KO, Kang HW, Park JH, Bidlot JR, Ward B. Kang SK, et al. Among authors: park yh, park jh. Nat Commun. 2024 Mar 7;15(1):1742. doi: 10.1038/s41467-024-45685-2. Nat Commun. 2024. PMID: 38453921 Free PMC article.
Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: A nationwide cohort study by the Korean Multiple Myeloma Working Party (KMM 2202).
Cho H, Kim K, Yoon SE, Jung SH, Lee JJ, Moon JH, Cho HJ, Lee HS, Kang KW, Kim SY, Eom HS, Mun YC, Park YH, Yoon SS, Do YR, Lee WS, Min CK, Yoon DH. Cho H, et al. Among authors: park yh. Hemasphere. 2024 Jan 26;8(1):e33. doi: 10.1002/hem3.33. eCollection 2024 Jan. Hemasphere. 2024. PMID: 38434530 Free PMC article. No abstract available.
Subsequent correlated changes in complement component 3 and amyloid beta oligomers in the blood of patients with Alzheimer's disease.
Shim KH, Kim D, Kang MJ, Pyun JM, Park YH, Youn YC, Park KW, Suk K, Lee HW, Gomes BF, Zetterberg H, An SSA, Kim S; Alzheimer's Disease All Markers (ADAM) Research group. Shim KH, et al. Among authors: park yh, park kw. Alzheimers Dement. 2024 Apr;20(4):2731-2741. doi: 10.1002/alz.13734. Epub 2024 Feb 27. Alzheimers Dement. 2024. PMID: 38411315 Free PMC article.
Interrupting an IFN-γ-dependent feedback loop in the syndrome of pyogenic arthritis with pyoderma gangrenosum and acne.
Lee W, Stone DL, Hoffmann P, Rosenzweig S, Tsai WL, Gadina M, Romeo T, Lee CR, Randazzo D, Pimpale Chavan P, Manthiram K, Canna S, Park YH, Ombrello AK, Aksentijevich I, Kastner DL, Chae JJ. Lee W, et al. Among authors: park yh. Ann Rheum Dis. 2024 Feb 26:ard-2023-225085. doi: 10.1136/ard-2023-225085. Online ahead of print. Ann Rheum Dis. 2024. PMID: 38408849 Free article.
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522.
Pusztai L, Denkert C, O'Shaughnessy J, Cortes J, Dent R, McArthur H, Kümmel S, Bergh J, Park YH, Hui R, Harbeck N, Takahashi M, Untch M, Fasching PA, Cardoso F, Zhu Y, Pan W, Tryfonidis K, Schmid P. Pusztai L, et al. Among authors: park yh. Ann Oncol. 2024 May;35(5):429-436. doi: 10.1016/j.annonc.2024.02.002. Epub 2024 Feb 17. Ann Oncol. 2024. PMID: 38369015 Clinical Trial.
The Usefulness of 18F-FDG PET to Differentiate Subtypes of Dementia: The Systematic Review and Meta-Analysis.
Na S, Kang DW, Kim GH, Kim KW, Kim Y, Kim HJ, Park KH, Park YH, Byeon G, Suh J, Shin JH, Shim Y, Yang Y, Um YH, Oh SI, Wang SM, Yoon B, Yoon HJ, Lee SM, Lee J, Lee JS, Rhee HY, Lim JS, Jung YH, Chin J, Hong YJ, Jang H, Choi H, Choi M, Jang JW; Korean Dementia Association. Na S, et al. Among authors: park yh, park kh. Dement Neurocogn Disord. 2024 Jan;23(1):54-66. doi: 10.12779/dnd.2024.23.1.54. Epub 2024 Jan 31. Dement Neurocogn Disord. 2024. PMID: 38362056 Free PMC article.
Dual regulatory effects of neferine on amyloid-β and tau aggregation studied by in silico, in vitro, and lab-on-a-chip technology.
Nam Y, Prajapati R, Kim S, Shin SJ, Cheong DY, Park YH, Park HH, Lim D, Yoon Y, Lee G, Jung HA, Park I, Kim DH, Choi JS, Moon M. Nam Y, et al. Among authors: park hh, park yh, park i. Biomed Pharmacother. 2024 Mar;172:116226. doi: 10.1016/j.biopha.2024.116226. Epub 2024 Feb 1. Biomed Pharmacother. 2024. PMID: 38301421 Free article.
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15).
Baek SK, Jeong JH, Jung K, Ahn HK, Kim MH, Sohn J, Park IH, Ahn JS, Lee DW, Im SA, Sim SH, Lee KS, Hyun Kim J, Shim HJ, Chae Y, Koh SJ, Lee H, Lee J, Byun JH, Seol Y, Lee EM, Jee HJ, An H, Park EB, Suh YJ, Lee KE, Park YH; Korean Cancer Study Group (KCSG). Baek SK, et al. Among authors: park ih, park yh, park eb. Ther Adv Med Oncol. 2024 Jan 28;16:17588359231225029. doi: 10.1177/17588359231225029. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38288157 Free PMC article.
Intravascular Imaging-Guided Percutaneous Coronary Intervention Before and After Standardized Optimization Protocols.
Kwon W, Hong D, Choi KH, Lee SH, Shin D, Lee JY, Lee SJ, Lee SY, Kim SM, Yun KH, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Park YH, Lee WS, Park TK, Yang JH, Choi SH, Gwon HC, Song YB, Hahn JY, Lee JM; RENOVATE-COMPLEX-PCI Investigators. Kwon W, et al. Among authors: park yh, park tk. JACC Cardiovasc Interv. 2024 Jan 22;17(2):292-303. doi: 10.1016/j.jcin.2023.10.062. JACC Cardiovasc Interv. 2024. PMID: 38267144
Uncovering the colorectal cancer immunotherapeutic potential: Evening primrose (Oenothera biennis) root extract and its active compound oenothein B targeting the PD-1/PD-L1 blockade.
Lee EJ, Kim YS, Kim JH, Woo KW, Park YH, Ha JH, Li W, Kim TI, An BK, Cho HW, Han JH, Choi JG, Chung HS. Lee EJ, et al. Among authors: park yh. Phytomedicine. 2024 Mar;125:155370. doi: 10.1016/j.phymed.2024.155370. Epub 2024 Jan 17. Phytomedicine. 2024. PMID: 38266440 Free article.
c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer.
Park J, Chang ES, Kim JY, Chelakkot C, Sung M, Song JY, Jung K, Lee JH, Choi JY, Kim NY, Lee H, Kang MR, Kwon MJ, Shin YK, Park YH, Choi YL. Park J, et al. Among authors: park yh. Breast Cancer Res. 2024 Jan 18;26(1):13. doi: 10.1186/s13058-024-01768-y. Breast Cancer Res. 2024. PMID: 38238761 Free PMC article.
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Balmaña J, Fasching PA, Couch FJ, Delaloge S, Labidi-Galy I, O'Shaughnessy J, Park YH, Eisen AF, You B, Bourgeois H, Gonçalves A, Kemp Z, Swampillai A, Jankowski T, Sohn JH, Poddubskaya E, Mukhametshina G, Aksoy S, Timcheva CV, Park-Simon TW, Antón-Torres A, John E, Baria K, Gibson I, Gelmon KA; LUCY investigators. Balmaña J, et al. Among authors: park yh, park simon tw. Breast Cancer Res Treat. 2024 Apr;204(2):237-248. doi: 10.1007/s10549-023-07165-x. Epub 2023 Dec 19. Breast Cancer Res Treat. 2024. PMID: 38112922 Free PMC article. Clinical Trial.
Cpne7 deficiency induces cellular senescence and premature aging of dental pulp.
Lee YS, Park YH, Hwang G, Seo H, Ki SH, Bai S, Son C, Roh SM, Park SJ, Lee DS, Lee JH, Seo YM, Shon WJ, Jeon D, Jang M, Kim SG, Seo BM, Lee G, Park JC. Lee YS, et al. Among authors: park yh, park jc, park sj. Aging Cell. 2024 Mar;23(3):e14061. doi: 10.1111/acel.14061. Epub 2023 Dec 17. Aging Cell. 2024. PMID: 38105557 Free PMC article.
Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trial.
Lee DW, Jung KH, Lee KH, Park YH, Lee KS, Sohn J, Ahn HK, Jeong JH, Koh SJ, Kim JH, Kim HJ, Lee KE, Kim HJ, Yang YW, Park KH, Lee J, Won HS, Kim TY, Im SA. Lee DW, et al. Among authors: park yh, park kh. Eur J Cancer. 2024 Jan;197:113456. doi: 10.1016/j.ejca.2023.113456. Epub 2023 Nov 20. Eur J Cancer. 2024. PMID: 38104354 Clinical Trial.
Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01).
Saura C, Modi S, Krop I, Park YH, Kim SB, Tamura K, Iwata H, Tsurutani J, Sohn J, Mathias E, Liu Y, Cathcart J, Singh J, Yamashita T. Saura C, et al. Among authors: park yh. Ann Oncol. 2024 Mar;35(3):302-307. doi: 10.1016/j.annonc.2023.12.001. Epub 2023 Dec 11. Ann Oncol. 2024. PMID: 38092229 Free article. Clinical Trial.
Intravascular Imaging in Patients With Complex Coronary Lesions and Chronic Kidney Disease.
Kwon W, Choi KH, Song YB, Park YH, Lee JM, Lee JY, Lee SJ, Lee SY, Kim SM, Yun KH, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Lee WS, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Hong D, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY; RENOVATE COMPLEX-PCI Investigators. Kwon W, et al. Among authors: park yh, park tk. JAMA Netw Open. 2023 Nov 1;6(11):e2345554. doi: 10.1001/jamanetworkopen.2023.45554. JAMA Netw Open. 2023. PMID: 38019512 Free PMC article. Clinical Trial.
Clinical Benefit of Intravascular Imaging Compared With Conventional Angiography in Left Main Coronary Artery Intervention.
Kwon W, Lee JM, Yun KH, Choi KH, Lee SJ, Lee JY, Lee SY, Kim SM, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Park YH, Lee WS, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Kang MG, Koh JS, Lee KY, Lim YH, Cho YH, Cho JM, Jang WJ, Chun KJ, Hong D, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY, Song YB; RENOVATE COMPLEX-PCI Investigators. Kwon W, et al. Among authors: park yh, park tk. Circ Cardiovasc Interv. 2023 Dec;16(12):e013359. doi: 10.1161/CIRCINTERVENTIONS.123.013359. Epub 2023 Nov 29. Circ Cardiovasc Interv. 2023. PMID: 38018841 Clinical Trial.
Incidence of and Influencing Factors for Arm Lymphedema After Salvage Treatment for an Isolated Locoregional Recurrence of Breast Cancer.
Kim N, Kim H, Hwang JH, Lee JE, Park W, Cho WK, Nam SJ, Kim SW, Yu J, Chae BJ, Lee SK, Ryu JM, Im YH, Ahn JS, Park YH, Kim JY, Kim TG. Kim N, et al. Among authors: park yh, park w. J Breast Cancer. 2023 Dec;26(6):544-557. doi: 10.4048/jbc.2023.26.e43. Epub 2023 Oct 5. J Breast Cancer. 2023. PMID: 37985381 Free PMC article.
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Takahashi M, Cortés J, Dent R, Pusztai L, McArthur H, Kümmel S, Denkert C, Park YH, Im SA, Ahn JH, Mukai H, Huang CS, Chen SC, Kim MH, Jia L, Li XT, Tryfonidis K, Karantza V, Iwata H, Schmid P. Takahashi M, et al. Among authors: park yh. JAMA Netw Open. 2023 Nov 1;6(11):e2342107. doi: 10.1001/jamanetworkopen.2023.42107. JAMA Netw Open. 2023. PMID: 37966841 Free PMC article. Clinical Trial.
Optical Coherence Tomography Compared With Intravascular Ultrasound and Angiography in Complex Coronary Artery Lesions.
Lee JM, Kim H, Lee JY, Choi KH, Song YB, Lee SJ, Lee SY, Kim SM, Yun KH, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Park YH, Lee WS, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Kang MG, Koh JS, Lee KY, Lim YH, Cho YH, Cho JM, Jang WJ, Chun KJ, Hong D, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY; RENOVATE COMPLEX-PCI Investigators. Lee JM, et al. Among authors: park yh, park tk. JACC Cardiovasc Imaging. 2024 Mar;17(3):336-338. doi: 10.1016/j.jcmg.2023.09.009. Epub 2023 Nov 8. JACC Cardiovasc Imaging. 2024. PMID: 37943231 No abstract available.
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer.
Kim N, Kim JY, Park W, Cho WK, Kim TG, Im YH, Ahn JS, Lee JE, Nam SJ, Kim SW, Yu J, Chae BJ, Lee SK, Ryu JM, Park YH, Kim H. Kim N, et al. Among authors: park yh, park w. Breast. 2023 Dec;72:103594. doi: 10.1016/j.breast.2023.103594. Epub 2023 Oct 30. Breast. 2023. PMID: 37924622 Free PMC article.
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16).
Kim SH, Im SA, Suh KJ, Lee KH, Kim MH, Sohn J, Park YH, Kim JY, Jeong JH, Lee KE, Choi IS, Park KH, Kim HJ, Cho EK, Park SY, Kim M, Kim JH. Kim SH, et al. Among authors: park yh, park kh, park sy. Eur J Cancer. 2023 Dec;195:113386. doi: 10.1016/j.ejca.2023.113386. Epub 2023 Oct 14. Eur J Cancer. 2023. PMID: 37890351 Free article. Clinical Trial.
Association of Prophylactic Distal Perfusion Cannulation With Mortality in Patients Receiving Venoarterial Extracorporeal Membrane Oxygenation.
Lee HH, Jang WJ, Ahn CM, Chun WJ, Oh JH, Park YH, Lee SJ, Hong SJ, Yang JH, Kim JS, Kim HC, Kim BK, Yu CW, Kim HJ, Bae JW, Ko YG, Choi D, Gwon HC, Hong MK, Jang Y. Lee HH, et al. Among authors: park yh. Am J Cardiol. 2023 Nov 15;207:418-425. doi: 10.1016/j.amjcard.2023.07.149. Epub 2023 Oct 3. Am J Cardiol. 2023. PMID: 37797547
Reply to Kentaro Inamura's Letter to the Editor re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.05.023.
Feng M, Matoso A, Epstein G, Fong M, Park YH, Gabrielson A, Patel S, Czerniak B, Compérat E, Hoffman-Censits J, Kates M, Kim S, McConkey D, Choi W. Feng M, et al. Among authors: park yh. Eur Urol. 2024 Apr;85(4):e122-e123. doi: 10.1016/j.eururo.2023.08.030. Epub 2023 Sep 27. Eur Urol. 2024. PMID: 37775361 No abstract available.
Understanding the heterogeneity of alloreactive natural killer cell function in kidney transplantation.
Ruan DF, Fribourg M, Yuki Y, Park YH, Martin M, Kelly G, Lee B, Miguel de Real R, Lee R, Geanon D, Kim-Schulze S, McCarthy M, Chun N, Cravedi P, Carrington M, Heeger PS, Horowitz A. Ruan DF, et al. Among authors: park yh. bioRxiv [Preprint]. 2023 Sep 5:2023.09.01.555962. doi: 10.1101/2023.09.01.555962. bioRxiv. 2023. PMID: 37732256 Free PMC article. Preprint.
Prognostic Impact of Intravascular Imaging-Guided Percutaneous Coronary Intervention in Chronic Total Occlusion.
Hong D, Kim SM, Lee SY, Choi KH, Song YB, Lee JY, Lee SJ, Yun KH, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Park YH, Lee WS, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Kang MG, Koh JS, Lee KY, Lim YH, Cho YH, Cho JM, Jang WJ, Chun KJ, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY, Lee JM; RENOVATE-COMPLEX-PCI Investigators. Hong D, et al. Among authors: park yh, park tk. Circulation. 2023 Sep 12;148(11):903-905. doi: 10.1161/CIRCULATIONAHA.123.065876. Epub 2023 Sep 11. Circulation. 2023. PMID: 37695832 No abstract available.
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study.
Hurvitz SA, Bardia A, Quiroga V, Park YH, Blancas I, Alonso-Romero JL, Vasiliev A, Adamchuk H, Salgado M, Yardley DA, Berzoy O, Zamora-Auñón P, Chan D, Spera G, Xue C, Ferreira E, Badovinac Crnjevic T, Pérez-Moreno PD, López-Valverde V, Steinseifer J, Fernando TM, Moore HM, Fasching PA; coopERA Breast Cancer study group. Hurvitz SA, et al. Among authors: park yh. Lancet Oncol. 2023 Sep;24(9):1029-1041. doi: 10.1016/S1470-2045(23)00268-1. Lancet Oncol. 2023. PMID: 37657462 Free article. Clinical Trial.
Structural insight into crystal structure of helicase domain of DDX53.
Park S, Yang JB, Park YH, Kim YK, Jeoung D, Kim HY, Jung HS. Park S, et al. Among authors: park yh. Biochem Biophys Res Commun. 2023 Oct 15;677:190-195. doi: 10.1016/j.bbrc.2023.08.022. Epub 2023 Aug 17. Biochem Biophys Res Commun. 2023. PMID: 37603933
Emerging role of vascular burden in AT(N) classification in individuals with Alzheimer's and concomitant cerebrovascular burdens.
Chun MY, Jang H, Kim SJ, Park YH, Yun J, Lockhart SN, Weiner M, De Carli C, Moon SH, Choi JY, Nam KR, Byun BH, Lim SM, Kim JP, Choe YS, Kim YJ, Na DL, Kim HJ, Seo SW. Chun MY, et al. Among authors: park yh. J Neurol Neurosurg Psychiatry. 2023 Dec 14;95(1):44-51. doi: 10.1136/jnnp-2023-331603. J Neurol Neurosurg Psychiatry. 2023. PMID: 37558399 Free PMC article.
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer.
Park YH, Im SA, Park K, Wen J, Lee KH, Choi YL, Lee WC, Min A, Bonato V, Park S, Ram S, Lee DW, Kim JY, Lee SK, Lee WW, Lee J, Kim M, Kim HS, Weinrich SL, Ryu HS, Kim TY, Dann S, Kim YJ, Fernandez DR, Koh J, Wang S, Park SY, Deng S, Powell E, Ravi RK, Bienkowska J, Rejto PA, Park WY, Kan Z. Park YH, et al. Among authors: park s, park sy, park k, park wy. Genome Med. 2023 Jul 20;15(1):55. doi: 10.1186/s13073-023-01201-7. Genome Med. 2023. PMID: 37475004 Free PMC article.
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study.
Meric-Bernstam F, Calvo E, Lee KS, Moreno V, Park YH, Rha SY, Chalasani P, Zhong W, Zhou L, Pirie-Shepherd S, Leung ACF, Curigliano G. Meric-Bernstam F, et al. Among authors: park yh. Mol Cancer Ther. 2023 Oct 2;22(10):1191-1203. doi: 10.1158/1535-7163.MCT-23-0101. Mol Cancer Ther. 2023. PMID: 37420274 Free PMC article. Clinical Trial.
Predictors of Early and Late Response to Esomezol and Lifestyle Modification in Adults With Laryngopharyngeal Reflux Disease: A Prospective, Multicenter, Open-Label Cohort Study.
Kwon SK, Park SJ, Chung EJ, Sohn JH, Sun DI, Jin SM, Lee BJ, Park IS, Cho JG, Park YH. Kwon SK, et al. Among authors: park yh, park is, park sj. Clin Exp Otorhinolaryngol. 2023 Aug;16(3):259-274. doi: 10.21053/ceo.2023.00409. Epub 2023 Jun 19. Clin Exp Otorhinolaryngol. 2023. PMID: 37350172 Free PMC article.
Comparing 12-core and 20-core biopsy for prostate cancer diagnosis with transperineal MR/US fusion biopsy: assessing the effective number of systemic cores using propensity score matching.
Kwon HJ, Rhew SA, Yoon CE, Shin D, Bang S, Park YH, Cho HJ, Ha US, Hong SH, Lee JY, Kim SW, Moon HW. Kwon HJ, et al. Among authors: park yh. Int Urol Nephrol. 2023 Oct;55(10):2465-2471. doi: 10.1007/s11255-023-03674-2. Epub 2023 Jun 20. Int Urol Nephrol. 2023. PMID: 37340208 Free PMC article.
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer.
Sung C, An J, Lee S, Park J, Lee KS, Kim IH, Han JY, Park YH, Kim JH, Kang EJ, Hong MH, Kim TY, Lee JC, Lee JL, Yoon S, Choi CM, Lee DH, Yoo C, Kim SW, Jeong JH, Seo S, Kim SY, Kong SY, Choi JK, Park SR. Sung C, et al. Among authors: park yh, park sr, park j. Nat Cancer. 2023 Jun;4(6):844-859. doi: 10.1038/s43018-023-00572-5. Epub 2023 Jun 12. Nat Cancer. 2023. PMID: 37308678
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group. Turner NC, et al. Among authors: park yh. N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131. N Engl J Med. 2023. PMID: 37256976 Clinical Trial.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer.
Im SA, Gennari A, Park YH, Kim JH, Jiang ZF, Gupta S, Fadjari TH, Tamura K, Mastura MY, Abesamis-Tiambeng MLT, Lim EH, Lin CH, Sookprasert A, Parinyanitikul N, Tseng LM, Lee SC, Caguioa P, Singh M, Naito Y, Hukom RA, Smruti BK, Wang SS, Kim SB, Lee KH, Ahn HK, Peters S, Kim TW, Yoshino T, Pentheroudakis G, Curigliano G, Harbeck N. Im SA, et al. Among authors: park yh. ESMO Open. 2023 Jun;8(3):101541. doi: 10.1016/j.esmoop.2023.101541. Epub 2023 May 11. ESMO Open. 2023. PMID: 37178669 Free PMC article.
The Clinical Outcomes of Marginal Donor Hearts: A Single Center Experience.
Lee SY, Kim SH, Ju MH, Lim MH, Lee CH, Je HG, Lim JH, Kim GY, Oh JS, Choi JH, Chon MK, Lee SH, Hwang KW, Kim JS, Park YH, Kim JH, Chun KJ. Lee SY, et al. Among authors: park yh. Korean Circ J. 2023 Apr;53(4):254-267. doi: 10.4070/kcj.2022.0197. Korean Circ J. 2023. PMID: 37161684 Free PMC article.
Comparison of initial and sequential salvage brain-directed treatment in patients with 1-4 vs. 5-10 brain metastases from breast cancer (KROG 16-12).
Kim JS, Kim K, Jung W, Shin KH, Im SA, Kim HJ, Kim YB, Chang JS, Kim JH, Choi DH, Park YH, Kim DY, Kim TH, Choi BO, Lee SW, Kim S, Kwon J, Kang KM, Chung WK, Kim KS, Yoon WS, Kim JH, Cha J, Oh YK, Kim IA. Kim JS, et al. Among authors: park yh. Breast Cancer Res Treat. 2023 Jul;200(1):37-45. doi: 10.1007/s10549-023-06936-w. Epub 2023 May 3. Breast Cancer Res Treat. 2023. PMID: 37138198
Pancreatic Tumor-Targeting Stemsome Therapeutics.
Park JY, Park JY, Jeong YG, Park JH, Park YH, Kim SH, Khang D. Park JY, et al. Among authors: park yh, park jh. Adv Mater. 2023 Jul;35(30):e2300934. doi: 10.1002/adma.202300934. Epub 2023 Jun 11. Adv Mater. 2023. PMID: 37114740
Vaginal Infections during Pregnancy Increase Breast Milk Microbiome Alpha Diversity and Alter Taxonomic Composition.
Nisaa AA, Oon CE, Sreenivasan S, Balakrishnan V, Rajendran D, Tan JJ, Roslan FF, Todorov SD, Jeong WS, Zhao F, Nasir NSM, Deris ZZ, Zhang H, Park YH, Liu G, Liong MT. Nisaa AA, et al. Among authors: park yh. Prev Nutr Food Sci. 2023 Mar 31;28(1):1-9. doi: 10.3746/pnf.2023.28.1.1. Prev Nutr Food Sci. 2023. PMID: 37066035 Free PMC article.
3,003 results